|Articles|May 1, 2005

Jaundice in a newborn: How to head off an urgent situation. Second of two parts.

Extreme hyperbilirubinemia must be treated swiftly to prevent neurologic damage. Here are methods for determining a newborn's likelihood of developing severe jaundice and guidelines for treating those judged at greatest risk.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Jaundice in a newborn: How to head off an urgent situation. Second of two parts.

Related Content

FDA clears Capvaxive as supplemental PCV for at-risk children

Journal Club: Small renal stones can be managed conservatively

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Recognizing and managing allergic skin conditions across pediatric populations

Journal Club: Ultrasound is not reliable for diagnosing ankle fractures

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Recognizing and managing allergic skin conditions across pediatric populations

Vosoritide data support planned FDA submission for hypochondroplasia